Report Detail
Global Infantile Spasm Treatment Market 2019 by Company, Regions, Type and Application, Forecast to 2024
- RnM3693785 |
- 23 August, 2019 |
- Global |
- 124 Pages |
- GIR (Global Info Research) |
- Other
An infantile spasm (IS), also known as West Syndrome, is a specific type of seizure seen in an epilepsy syndrome of infancy and childhood. West Syndrome is characterized by infantile spasms, developmental regression, and a specific pattern on electroencephalography (EEG) testing called hypsarrhythmia (chaotic brain waves). The onset of infantile spasms is usually in the first year of life, typically between 4-8 months. The seizures primarily consist of a sudden bending forward of the body with stiffening of the arms and legs; some children arch their backs as they extend their arms and legs. The condition is usually observed in 2% of childhood epilepsies and 25% of epilepsies that start in the first year of life.
Scope of the Report:
The global Infantile Spasm Treatment market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Infantile Spasm Treatment.
Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.
This report studies the Infantile Spasm Treatment market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Infantile Spasm Treatment market by product type and applications/end industries.
Market Segment by Companies, this report covers
Mallinckrodt
H. Lundbeck
Insys Therapeutics
Orphelia Pharma
Valerion Therapeutics
Catalyst Pharmaceuticals
Anavex Life Sciences
Retrophin
GW Pharmaceuticals
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Oral
Parenteral
Market Segment by Applications, can be divided into
Hospital
Clinic
Other
Table of Contents
1 Infantile Spasm Treatment Market Overview
- 1.1 Product Overview and Scope of Infantile Spasm Treatment
- 1.2 Classification of Infantile Spasm Treatment by Types
- 1.2.1 Global Infantile Spasm Treatment Revenue Comparison by Types (2019-2024)
- 1.2.2 Global Infantile Spasm Treatment Revenue Market Share by Types in 2018
- 1.2.3 Oral
- 1.2.4 Parenteral
- 1.3 Global Infantile Spasm Treatment Market by Application
- 1.3.1 Global Infantile Spasm Treatment Market Size and Market Share Comparison by Applications (2014-2024)
- 1.3.2 Hospital
- 1.3.3 Clinic
- 1.3.4 Other
- 1.4 Global Infantile Spasm Treatment Market by Regions
- 1.4.1 Global Infantile Spasm Treatment Market Size (Million USD) Comparison by Regions (2014-2024)
- 1.4.1 North America (USA, Canada and Mexico) Infantile Spasm Treatment Status and Prospect (2014-2024)
- 1.4.2 Europe (Germany, France, UK, Russia and Italy) Infantile Spasm Treatment Status and Prospect (2014-2024)
- 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Infantile Spasm Treatment Status and Prospect (2014-2024)
- 1.4.4 South America (Brazil, Argentina, Colombia) Infantile Spasm Treatment Status and Prospect (2014-2024)
- 1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Infantile Spasm Treatment Status and Prospect (2014-2024)
- 1.5 Global Market Size of Infantile Spasm Treatment (2014-2024)
2 Manufacturers Profiles
- 2.1 Mallinckrodt
- 2.1.1 Business Overview
- 2.1.2 Infantile Spasm Treatment Type and Applications
- 2.1.2.1 Product A
- 2.1.2.2 Product B
- 2.1.3 Mallinckrodt Infantile Spasm Treatment Revenue, Gross Margin and Market Share (2017-2018)
- 2.2 H. Lundbeck
- 2.2.1 Business Overview
- 2.2.2 Infantile Spasm Treatment Type and Applications
- 2.2.2.1 Product A
- 2.2.2.2 Product B
- 2.2.3 H. Lundbeck Infantile Spasm Treatment Revenue, Gross Margin and Market Share (2017-2018)
- 2.3 Insys Therapeutics
- 2.3.1 Business Overview
- 2.3.2 Infantile Spasm Treatment Type and Applications
- 2.3.2.1 Product A
- 2.3.2.2 Product B
- 2.3.3 Insys Therapeutics Infantile Spasm Treatment Revenue, Gross Margin and Market Share (2017-2018)
- 2.4 Orphelia Pharma
- 2.4.1 Business Overview
- 2.4.2 Infantile Spasm Treatment Type and Applications
- 2.4.2.1 Product A
- 2.4.2.2 Product B
- 2.4.3 Orphelia Pharma Infantile Spasm Treatment Revenue, Gross Margin and Market Share (2017-2018)
- 2.5 Valerion Therapeutics
- 2.5.1 Business Overview
- 2.5.2 Infantile Spasm Treatment Type and Applications
- 2.5.2.1 Product A
- 2.5.2.2 Product B
- 2.5.3 Valerion Therapeutics Infantile Spasm Treatment Revenue, Gross Margin and Market Share (2017-2018)
- 2.6 Catalyst Pharmaceuticals
- 2.6.1 Business Overview
- 2.6.2 Infantile Spasm Treatment Type and Applications
- 2.6.2.1 Product A
- 2.6.2.2 Product B
- 2.6.3 Catalyst Pharmaceuticals Infantile Spasm Treatment Revenue, Gross Margin and Market Share (2017-2018)
- 2.7 Anavex Life Sciences
- 2.7.1 Business Overview
- 2.7.2 Infantile Spasm Treatment Type and Applications
- 2.7.2.1 Product A
- 2.7.2.2 Product B
- 2.7.3 Anavex Life Sciences Infantile Spasm Treatment Revenue, Gross Margin and Market Share (2017-2018)
- 2.8 Retrophin
- 2.8.1 Business Overview
- 2.8.2 Infantile Spasm Treatment Type and Applications
- 2.8.2.1 Product A
- 2.8.2.2 Product B
- 2.8.3 Retrophin Infantile Spasm Treatment Revenue, Gross Margin and Market Share (2017-2018)
- 2.9 GW Pharmaceuticals
- 2.9.1 Business Overview
- 2.9.2 Infantile Spasm Treatment Type and Applications
- 2.9.2.1 Product A
- 2.9.2.2 Product B
- 2.9.3 GW Pharmaceuticals Infantile Spasm Treatment Revenue, Gross Margin and Market Share (2017-2018)
3 Global Infantile Spasm Treatment Market Competition, by Players
- 3.1 Global Infantile Spasm Treatment Revenue and Share by Players (2014-2019)
- 3.2 Market Concentration Rate
- 3.2.1 Top 5 Infantile Spasm Treatment Players Market Share
- 3.2.2 Top 10 Infantile Spasm Treatment Players Market Share
- 3.3 Market Competition Trend
4 Global Infantile Spasm Treatment Market Size by Regions
- 4.1 Global Infantile Spasm Treatment Revenue and Market Share by Regions
- 4.2 North America Infantile Spasm Treatment Revenue and Growth Rate (2014-2019)
- 4.3 Europe Infantile Spasm Treatment Revenue and Growth Rate (2014-2019)
- 4.4 Asia-Pacific Infantile Spasm Treatment Revenue and Growth Rate (2014-2019)
- 4.5 South America Infantile Spasm Treatment Revenue and Growth Rate (2014-2019)
- 4.6 Middle East and Africa Infantile Spasm Treatment Revenue and Growth Rate (2014-2019)
5 North America Infantile Spasm Treatment Revenue by Countries
- 5.1 North America Infantile Spasm Treatment Revenue by Countries (2014-2019)
- 5.2 USA Infantile Spasm Treatment Revenue and Growth Rate (2014-2019)
- 5.3 Canada Infantile Spasm Treatment Revenue and Growth Rate (2014-2019)
- 5.4 Mexico Infantile Spasm Treatment Revenue and Growth Rate (2014-2019)
6 Europe Infantile Spasm Treatment Revenue by Countries
- 6.1 Europe Infantile Spasm Treatment Revenue by Countries (2014-2019)
- 6.2 Germany Infantile Spasm Treatment Revenue and Growth Rate (2014-2019)
- 6.3 UK Infantile Spasm Treatment Revenue and Growth Rate (2014-2019)
- 6.4 France Infantile Spasm Treatment Revenue and Growth Rate (2014-2019)
- 6.5 Russia Infantile Spasm Treatment Revenue and Growth Rate (2014-2019)
- 6.6 Italy Infantile Spasm Treatment Revenue and Growth Rate (2014-2019)
7 Asia-Pacific Infantile Spasm Treatment Revenue by Countries
- 7.1 Asia-Pacific Infantile Spasm Treatment Revenue by Countries (2014-2019)
- 7.2 China Infantile Spasm Treatment Revenue and Growth Rate (2014-2019)
- 7.3 Japan Infantile Spasm Treatment Revenue and Growth Rate (2014-2019)
- 7.4 Korea Infantile Spasm Treatment Revenue and Growth Rate (2014-2019)
- 7.5 India Infantile Spasm Treatment Revenue and Growth Rate (2014-2019)
- 7.6 Southeast Asia Infantile Spasm Treatment Revenue and Growth Rate (2014-2019)
8 South America Infantile Spasm Treatment Revenue by Countries
- 8.1 South America Infantile Spasm Treatment Revenue by Countries (2014-2019)
- 8.2 Brazil Infantile Spasm Treatment Revenue and Growth Rate (2014-2019)
- 8.3 Argentina Infantile Spasm Treatment Revenue and Growth Rate (2014-2019)
- 8.4 Colombia Infantile Spasm Treatment Revenue and Growth Rate (2014-2019)
9 Middle East and Africa Revenue Infantile Spasm Treatment by Countries
- 9.1 Middle East and Africa Infantile Spasm Treatment Revenue by Countries (2014-2019)
- 9.2 Saudi Arabia Infantile Spasm Treatment Revenue and Growth Rate (2014-2019)
- 9.3 UAE Infantile Spasm Treatment Revenue and Growth Rate (2014-2019)
- 9.4 Egypt Infantile Spasm Treatment Revenue and Growth Rate (2014-2019)
- 9.5 Nigeria Infantile Spasm Treatment Revenue and Growth Rate (2014-2019)
- 9.6 South Africa Infantile Spasm Treatment Revenue and Growth Rate (2014-2019)
10 Global Infantile Spasm Treatment Market Segment by Type
- 10.1 Global Infantile Spasm Treatment Revenue and Market Share by Type (2014-2019)
- 10.2 Global Infantile Spasm Treatment Market Forecast by Type (2019-2024)
- 10.3 Oral Revenue Growth Rate (2014-2024)
- 10.4 Parenteral Revenue Growth Rate (2014-2024)
11 Global Infantile Spasm Treatment Market Segment by Application
- 11.1 Global Infantile Spasm Treatment Revenue Market Share by Application (2014-2019)
- 11.2 Infantile Spasm Treatment Market Forecast by Application (2019-2024)
- 11.3 Hospital Revenue Growth (2014-2019)
- 11.4 Clinic Revenue Growth (2014-2019)
- 11.5 Other Revenue Growth (2014-2019)
12 Global Infantile Spasm Treatment Market Size Forecast (2019-2024)
- 12.1 Global Infantile Spasm Treatment Market Size Forecast (2019-2024)
- 12.2 Global Infantile Spasm Treatment Market Forecast by Regions (2019-2024)
- 12.3 North America Infantile Spasm Treatment Revenue Market Forecast (2019-2024)
- 12.4 Europe Infantile Spasm Treatment Revenue Market Forecast (2019-2024)
- 12.5 Asia-Pacific Infantile Spasm Treatment Revenue Market Forecast (2019-2024)
- 12.6 South America Infantile Spasm Treatment Revenue Market Forecast (2019-2024)
- 12.7 Middle East and Africa Infantile Spasm Treatment Revenue Market Forecast (2019-2024)
13 Research Findings and Conclusion
14 Appendix
- 14.1 Methodology
Summary:
Get latest Market Research Reports on Infantile Spasm Treatment. Industry analysis & Market Report on Infantile Spasm Treatment is a syndicated market report, published as Global Infantile Spasm Treatment Market 2019 by Company, Regions, Type and Application, Forecast to 2024. It is complete Research Study and Industry Analysis of Infantile Spasm Treatment market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
